A Double-Blind Placebo Controlled Trial of Divalproex [valproate semisodium] and Olanzapine in Bipolar I Disorder, Mixed Episode.
Phase of Trial: Phase IV
Latest Information Update: 01 Nov 2009
At a glance
- Drugs Olanzapine; Valproate semisodium
- Indications Bipolar I disorders
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 01 Nov 2009 Results published in the Journal of Clinical Psychiatry.
- 02 Jun 2009 Actual patient number changed from 199 to 202 as reported by ClinicalTrials.gov.
- 02 Jun 2009 Trial phase changed from III to IV as reported by ClinicalTrials.gov.